Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuation of Treatment and Monitoring of Safety in Patients Treated With LY353381 for Advanced Cancer

NCT00190697 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00190697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00190697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuation of Treatment and Monitoring of Safety in Patients Treated With LY353381 for Advanced Cancer
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2001
Completion date
April 30, 2007
Enrollment
70
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, endometrial cancer, ovarian cancer